miR-106a通过向患有骨关节炎的老鼠的DR6来模仿核因子-κB信号通路
Luping Cui1, Yongbin Han2, Zhijie Dong3
1Department of Rheumatology and Immunology, Shanxi Provincial People's Hospital, Taiyuan, Shanxi Province, China.
Archives of medical science : AMS
|February 28, 2024
概括
在骨关节炎模型中,MicroRNA-106a模仿减少炎症和亡. 这项研究表明,miR-106a通过通过NF-κB通路激活死亡受体6来保护软骨.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 骨关节炎 (OA) 是一种普遍的炎症性关节疾病,以软骨退化为标志,这对治疗提出了重大挑战.
- 目前的OA管理策略是有限的,需要开发新的治疗方法.
研究的目的:
- 为了研究微RNA-106a (miR-106a) 在已建立的骨关节炎 (OA) 动物模型中模仿的潜在保护作用.
主要方法:
- 利用体外 (老鼠冠状细胞) 和体内 (老鼠OA模型) 系统来评估miR-106a模仿疗效.
- 使用脂聚糖 (LPS) 诱导炎症;评估了对细胞因子产生,细胞亡和蛋白质表达 (DR6,NF-κB通路) 的影响.
主要成果:
- 在LPS引起的炎症中,miR-106a模仿治疗显著降低了炎症性细胞因子和亡蛋白水平.
- 模仿剂减弱了红细胞中DR6,IκBα和p65蛋白的表达,并在体内OA模型中改善了他的病理结果.
结论:
- 通过通过NF-κB信号通路激活死亡受体6 (DR6),miR-106a模仿剂的使用可改善OA软骨中的炎症.
- 这些发现突出了miR-106a作为骨关节炎治疗的潜在治疗剂.
相关概念视频
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


